$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Health-industry linkages for local health: reframing policies for African health system strengthening 원문보기

Health policy and planning, v.33 no.4, 2018년, pp.602 - 610  

Mackintosh, Maureen (Faculty of Arts and Social Sciences, The Open University, Walton Hall, Milton Keynes MK7 6AA, UK) ,  Mugwagwa, Julius (Department of Science, Technology, Engineering and Public Policy, University College London, London W1T 6EY, UK) ,  Banda, Geoffrey (Science, Technology and Innovation Studies, University of Edinburgh, Edinburgh EH1 1LZ, UK) ,  Tibandebage, Paula (Economic and Social Research Foundation, Dar es Salaam, Tanzania) ,  Tunguhole, Jires (Economic and Social Research Foundation, Dar es Salaam, Tanzania) ,  Wangwe, Samuel (Economic and Social Research Foundation, Dar es Salaam, Tanzania) ,  Karimi Njeru, Mercy (Centre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya)

Abstract AI-Helper 아이콘AI-Helper

AbstractThe benefits of local production of pharmaceuticals in Africa for local access to medicines and to effective treatment remain contested. There is scepticism among health systems experts internationally that production of pharmaceuticals in sub-Saharan Africa (SSA) can provide competitive pri...

주제어

참고문헌 (75)

  1. ACT Watch Group Tougher S , Hansen K , Goodman C. 2017 What happened to anti-malarial markets after the Affordable Medicines Facility malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism . Malaria Journal 16 : 173 . 28441956 

  2. African Union . 2007 Pharmaceutical Plan for Africa African Union Commission, Addis Ababa www.unido.org/fileadmin/user_media/Services/PSD/BEP/Pharmaceutical%20manufacturing%20plan%20for%20Africa-English.pdf , accessed 22 May 2010. 

  3. African Union . 2012 Pharmaceutical Manufacturing Plan for Africa Business Plan , Addis Ababa http://sa.au.int/en/sites/default/files/pmpa%20bp%20ebook.pdf , accessed 30 April 2015. 

  4. African Union . 2014a AGENDA 2063 The Africa We Want A Shared Strategic Framework for Inclusive Growth and Sustainable Development FIRST TEN-YEAR IMPLEMENTATION PLAN 2014–2023 African Union Commission. http://archive.au.int/assets/images/agenda2063.pdf . 

  5. African Union . 2014b Science, Technology and Innovation Strategy for Africa (STISA 2024) African Union Commission, Addis Ababa. https://au.int/sites/default/files/newsevents/workingdocuments/33178-wd-stisa-english_-_final.pdf . 

  6. Aldis W. 2008 Health security as a public health concept: a critical analysis . Health Policy and Planning 23 : 369 – 75 . 18689437 

  7. Battams S , Matlin S. ( 2013 ). Discussing a definition of global health Global health diplomacy briefing. Graduate Institute. Geneva. http://graduateinstitute.ch/files/live/sites/iheid/files/sites/globalhealth/shared/1894/Publications/Publications%202013/Definition_Global_Health_v3.pdf , accessed 2 June 2017. 

  8. Berger M , Murugi J , Buch E ( 2010 ). Strengthening pharmaceutical innovation in Africa Geneva and Johannesburg: Council on Health Research for Development (COHRED) and The New Partnership for Africa’s Development (NEPAD) Agency of the African Union. www.nepad.org/download/file/fid/600%20 , accessed 5 June 2017. 

  9. Bigdeli M , Peters DH , Wagner AK. ( 2014 ) Medicines in Health Systems: Advancing Access, Affordability and Appropriate Use. Geneva : Alliance for Health Policy and Systems Research, WHO . 

  10. Boschma R. 2005 Proximity and innovation: a critical assessment . Regional Studies 39 : 61 – 74 . 

  11. Chataway J , Banda G , Cochrane G , Manville C. ( 2016 ) Innovative procurement for health and industrial development In: Mackintosh M. , Banda G. , Tibandebage P. , Wamae W (eds). Making Medicines in Africa: The Political Economy of Industrializing for Local Health . London : Palgrave Macmillan . 

  12. Chaudhuri S , West A. 2014 Can local producers compete with low cost imports? A simulation study of pharmaceutical industry in low income Africa . Innovation and Development 5 : 23 – 38 . 

  13. Cohen JM , Sabot O , Sabot K 2010 A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops . BMC Health Services Research 10 : S6. 20594372 

  14. Commission on Social Determinants of Health (CSDH) . 2008 Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health . Final Report of the Commission on Social Determinants of Health. Geneva , World Health Organization http://apps.who.int/iris/bitstream/10665/43943/1/9789241563703_eng.pdf . 

  15. Dinh HT , Palmade V , Chandra V , Cossar F. 2012 Light Manufacturing in Africa . Washington, DC : World Bank . 

  16. East African Community (EAC) . 2011 Regional Pharmaceutical Manufacturing Plan of Action 2012-2016 , Arusha, Tanzania; EAC Secretariat, http://feapm.com/fileadmin/user_upload/documents/EAC_Regional_Pharmaceutical_Manufacturing_Plan_of_Action.pdf , accessed 3 May 2015. 

  17. Eriksen SN. 2013 Defining local food: constructing a new taxonomy—three domains of proximity . Acta Agriculturae Scandinavica, Section B—Soil & Plant Science 63 : 47 – 55 . 

  18. Ernst D , Lundvall B-A , 1997 Information Technology in The Learning Economy-Challenges for Developing Countries . DRUID Working Papers 97–12 , DRUID, Copenhagen Business School/Aalborg University. 

  19. Ewen M , Kaplan W , Gedif T 2017 Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania . Journal of Pharmaceutical Policy and Practice 10 : 7 . 28116107 

  20. Federal Democratic Republic of Ethiopia (FDRE) . 2015 National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia ( 2015–2025): Developing the pharmaceutical industry and improving access Ministry of Health and Ministry of Industry, Addis Ababa, July. 

  21. Flahault A , Wernli D , Zylberman P , Tanner M. 2016 From global health security to global health solidarity and sustainability . Bulletin of the World Health Organization 94 : 863. 27994276 

  22. Gebre-Mariam T , Tahir K , Gebre-Amanuel S. ( 2016 ) Bringing industrial and health policies closer: reviving pharmaceutical production in Ethiopia In: Mackintosh M , Banda G , Tibandebage P , Wamae W. (eds). Making Medicines in Africa: The Political Economy of Industrializing for Local Health . London : Palgrave Macmillan . Open access. 

  23. Giddens A. 1999 Risk and responsibility . Modern Law Review 62 : 1 – 12 . 

  24. Government of Kenya . 2010 National Industrialisation Policy Framework , Draft Five, Ministry of Industrialisation, Nairobi. http://industrialization.eac.int/index.php? option=com_docman&task=doc_download&gid=115&Itemid=70 , accessed 27 April 2015. 

  25. Government of Uganda . 2002 Uganda National Drug Policy Ministry of Health, Kampala. 

  26. Hahn RA , Inhorn MC (eds). 2009 Anthropology and Public Health: Bridging Differences in Culture and Society . Oxford : Oxford University Press . 

  27. Horton R. 2014 Offline: the case against global health . The Lancet 383 : 1693 – 780 . 

  28. Institute for Health Metrics and Evaluation (IHME) . 2017 Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage . Seattle, WA : IHME . 

  29. Lopes C. 2014 Manufacturing Pharmaceuticals: An untapped Opportunity Africa Cheetah Run. The Former Executive Secretary’s Bog. UNECA. www.uneca.org/es-blog/manufacturing-pharmaceuticals-untapped-opportunity , accessed 18 May 2017. 

  30. Kaplan W , Laing R. 2005 Local production of pharmaceuticals: industrial policy and access to medicines: an overview of key concepts, issues and opportunities for future research. Health, Nutrition and Population Discussion Paper. World Bank , Washington DC . 

  31. Kaplan WA , Ritz LS , Vitello M. 2011 Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature . Southern Medical Review 4 : 51 – 61 . 

  32. Koplan JP , Bond TC , Merson MH 2009 Towards a common definition of global health . The Lancet 373 : 1993 – 1995 . 

  33. Kumar V , Kumar U , Persaud A 1999 Building technological capability through importing technology: the case of Indonesian manufacturing industry . The Journal of Technology Transfer 24 : 81 – 96 . 

  34. Lin JY. 2013 From flying geese to leading dragons: new opportunities and strategies for structural transformation in developing countries In: Stiglitz J , Lin JY , Patel E (eds). The Industrial Policy Revolution II: Africa in the 21st Century . Basingstoke : Palgrave Macmillan . 

  35. Macfarlane SB , Jacobs M , Kaaya EE. 2008 In the name of global health: trends in academic institutions . Journal of Public Health Policy 29 : 383 – 401 . 19079297 

  36. Mackintosh M , Chataway J , Wuyts M. 2007 Promoting innovation, productivity and industrial growth and reducing poverty: bridging the policy gap . European Journal of Development Research 19 : 1 – 11 . 

  37. Mackintosh M , Mujinja PGM. 2010 Markets and policy challenges in access to essential medicines for endemic disease . Journal of African Economies 19 : iii166 – 200 . 

  38. Mackintosh M , Banda G , Tibandebage P , Wamae W. (eds.) ( 2016 ) Making Medicines in Africa: The Political Economy of Industrializing for Local Health . London : Palgrave Macmillan Open access http://www.palgrave.com/us/book/9781137546463 . 

  39. Malmberg A , Maskell P. 2002 The elusive concept of localization economies: Towards a knowledge-based theory of spatial clustering . Environment and Planning A 34 ( 3 ): 429 – 49 . 

  40. Ministry of Industry (MIT) and UNIDO . 2012 Tanzania Competitiveness Report MIT and President’s Office Planning Commission of the United Republic of Tanzania and UNIDO, Dar es Salaam. 

  41. Morris A , Ward A , Moonen B , Sabot O , Cohen JM. 2015 Price subsidies increase the use of private sector ACTs: evidence from a systematic review . Health Policy and Planning 30 : 397 – 405 . 24633915 

  42. Mujinja PGM , Mackintosh M , Justin-Temu M , Wuyts M. 2014 Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications . Globalization and Health 10 : 12. 24612518 

  43. Nadvi K , Halder G. 2005 Local clusters in global value chains: exploring dynamic linkages between Germany and Pakistan . Entrepreneurship and Regional Development 17 : 339 – 63 . 

  44. Ozawa S , Pongpirul K. 2014 10 best resources on …mixed methods in health systems . Health Policy and Planning 29 : 323 – 7 . 23564372 

  45. Ravix JL. 2014 Localization, innovation and entrepreneurship: an appraisal of the analytical impact of Marshall’s notion of industrial atmosphere . Journal of Innovation, Economics and Management 14 : 63 – 81 . 

  46. Republic of Ghana . 2004 Ghana National Drug Policy (Second Edition) . Accra : Ministry of Health . 

  47. Republic of Kenya . 2015 The Health Bill, 2015 Kenya Gazette Supplement: National Assembly Bills 2015, Nairobi 17th April. 

  48. Rowson M , Willott C , Hughes R 2012 Conceptualising global health: theoretical issues and their relevance for teaching . Globalization and Health 8 : 36. 23148788 

  49. Rushton S. 2011 Global health security: security for whom? Security from what? Political Studies 59 : 779 – 96 . 

  50. Seiter A. 2005 Pharmaceuticals: local manufacturing. HNP Brief 3 World Bank, Washington DC http://apps.who.int/medicinedocs/documents/s16758e/s16758e.pdf . 

  51. Schmitz H. 1995 Collective efficiency: growth path for small scale industry . Journal of Development Studies 31 : 529 – 66 . 

  52. Shadlen K , Massard da Fonseca E. 2013 Health Policy as Industrial Policy: Brazil in Comparative Perspective . Politics & Society 41 : 561 – 87 . 

  53. Sheikh K , Bennett SC , el Jardali F , Gotsadze G. 2017 Privilege and inclusivity in shaping Global Health agendas . Health Policy and Planning 32 : 303 – 4 . 27935804 

  54. Shiffman J , Schmitz HP , Berlan D , Smith SL , Quissell K , Gneiting U , Pelletier D. 2016 The emergence and effectiveness of global health networks: findings and future research . Health Policy and Planning 31 : i110 – 23 . 27067141 

  55. Sidibé M , Yong L , Chan M. 2014 Commodities for better health in Africa: time to invest locally . Bulletin of the World Health Organization 92 : 387 A . 24940007 

  56. Srinivas S. 2012 Market Menagerie. Health and Development in Late Industrial States . Stanford, CA : Stanford University Press . 

  57. Sutton J. 2012 Competing in Capabilities: The Globalization Process . Oxford: Oxford University Press . 

  58. UNCTAD . 2011 Local Production of Pharmaceuticals and Related Technology Transfer in Developing Countries: A Series of Case Studies . Geneva : UNCTAD . 

  59. United Nations (UN) . 2015 Taking Stock of the Global Partnership for Development Millennium Development Goal 8 MDG Gap Task Force Report United Nations , New York http://www.un.org/en/development/desa/policy/mdg_gap/mdg_gap2015/2015GAP_FULLREPORT_EN.pdf , accessed 2 June 2017. 

  60. United Republic of Tanzania (URT) . 2014 Household Budget Survey Main Report 2011/12 . Dar es Salaam : National Bureau of Statistics . 

  61. United Republic of Tanzania (URT) . 2016 National Five Year Development Plan , 2016/2017-2020/2021 Ministry of Finance and Planning, Dar es Salaam http://www.mof.go.tz/mofdocs/msemaji/Five%202016_17_2020_21.pdf , accessed 02 May 2017. 

  62. Waako PJ , Odoi-adome R , Obua C 2009 Existing capacity to manage pharmaceuticals and related commodities in East Africa . Human Resources for Health 7 : 21 . 19272134 

  63. Wagner AK , Graves AJ , Reiss SK 2011 Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey . Health Policy 100 : 151 – 8 . 20828854 

  64. West A , Banda G. ( 2016 ) Finance and incentives to support the development of national pharmaceutical industries In: Mackintosh M. , Banda G. , Tibandebage P. , Wamae W (eds). Making Medicines in Africa: The Political Economy of Industrializing for Local Health . London : Palgrave Macmillan . 

  65. Wiedenmayer KA , Kapologwe N , Charles J , Chilunda F , Mapunjo S. 2015 The reality of task shifting in medicines management—a case study from Tanzania . Journal of Pharmaceutical Policy and Practice 8 : 13. 25893096 

  66. Wilson KR , Kohler JC , Ovtcharenko N. 2012 The make or buy debate: considering the limitations of domestic production in Tanzania . Global Health 8 : 20 . 22747578 

  67. Wirtz VJ , Hogerzeil HV , Gray AL 2017 Essential medicines for universal health coverage . The Lancet 389 : 403 – 76 . 

  68. World Health Organisation (WHO) . 2011a Local Production for Access to Medical Products: Developing a Framework to Improve Public Health . Geneva : WHO . 

  69. World Health Organisation (WHO) . 2011b The World Medicines Situation . Geneva : WHO http://www.who.int/medicines/areas/policy/world_medicines_situation/en/ , accessed 1 June 2017. 

  70. World Health Organisation (WHO) . 2017a Towards Access 2030: WHO Medicines and Health Products Programme Strategic Framework 2016–2030 WHO , Geneva http://www.who.int/medicines/publications/Towards_Access_2030_Final.pdf? ua=1 , accessed 31 May 2017. 

  71. World Health Organisation (WHO) . 2017b World Health Statistics . Geneva : WHO . 

  72. World Health Organisation (WHO) . 2010 Monitoring the Building Blocks of Health Systems . Geneva : WHO . 

  73. WHO/World Bank . 2017 Healthy Systems for Universal Health Coverage—a Joint Vision for Healthy Lives Geneva WHO and IBRD https://www.uhc2030.org/fileadmin/uploads/ihp/Documents/About_IHP_/mgt_arrangemts___docs/UHC2030_Official_documents/UHC2030_vision_paper_WEB2.pdf . 

  74. Yadav P. 2014 Kenya Medical Supplies Authority (KEMSA): A Case Study of the Ongoing Transition from an Ungainly Bureaucracy to a Competitive and Customer-Focused Medical Logistics Organisation . Washington, DC : World Bank . 

  75. Yadav P. 2015 Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform . Health Systems and Reform 1 : 142 – 54 . 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로